Table 1 TINAGL1 and COL1A1 expression is associated with overall survival of DGC patients in the GSE15459 dataset

TINAGL1/COL1A1

 Others

64 (85.3)

–

–

 TINAGL1 + /COL1A1 + 

11 (14.7)

2.41 (1.09–5.28)

0.029

3.78 (1.37–10.41)

0.010

Age

 > 65

31 (41.3)

–

–

 65 ≥

44 (58.7)

0.80 (0.43–1.51)

0.498

0.77 (0.36–1.68)

0.516

Gender

 Female

39 (52.0)

–

–

 Male

36 (48.0)

1.55 (0.83–2.90)

0.170

0.93 (0.45–1.94)

0.845

Stage

 I

9 (12.0)

–

–

 II

12 (16.0)

7.98 (0.98–65.10)

0.052

10.87 (1.24–95.02)

0.031

 III

31 (41.3)

9.49 (1.25–72.24)

0.030

12.82 (1.57–104.51)

0.017

 IV

23 (30.7)

33.96 (4.36–264.71)

0.001

57.30 (6.64–494.59)

< 0.001

Subtype

 Metabolic

16 (26.2)

–

–

 Proliferative

12 (19.7)

1.51 (0.54–4.20)

0.427

0.72 (0.25–2.08)

0.541

 Mesenchymal

33 (54.1)

1.60 (0.71–3.63)

0.256

0.98 (0.40–2.41)

0.968